NCT00231816View on ClinicalTrials.gov

A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)

PHASE3CompletedINTERVENTIONAL
Enrollment

763

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

ZOSTAVAX™ (concomitant)

a single administration of 0.65 mL subcutaneous injection of zoster vaccine live on Day 1 and placebo at Week 4

BIOLOGICAL

Comparator: Influenza Vaccine

a single administration of 0.5 mL intramuscular injection of influenza vaccine (inactivated) at Day 1

BIOLOGICAL

ZOSTAVAX™ (Nonconcomitant)

Placebo injection on Day 1 and a single administration of 0.65 mL subcutaneous injection of zoster vaccine live at Week 4

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00231816 - A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011) | Biotech Hunter | Biotech Hunter